Dr. Lorenzo Galindo, MD
What this data tells you about Dr. Galindo
Dr. Lorenzo Galindo is a cytopathology physician in Darby, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Galindo performed 4,305 Medicare services across 3,908 unique beneficiaries.
Between the years covered by Open Payments, Dr. Galindo received a total of $71 from 4 pharmaceutical and/or device companies across 4 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cytopathology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Galindo is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Automated cervical cancer screening with manual review A cervical or vaginal sample is prepared using an automated thin-layer system. The sample is screened by an automated system and then manually rescreened under physician supervision. |
942 | $26 | $88 |
| Automated Pap test with manual rescreening A cervical cancer screening test using an automated system to prepare the sample, followed by a manual review to check for abnormalities. |
493 | $26 | $89 |
| Tissue pathology examination, moderate complexity A laboratory test where a pathologist examines tissue samples under a microscope to analyze cellular details. This intermediate complexity procedure involves specialized techniques to identify abnormalities in the tissue. |
465 | $53 | $211 |
| Nucleic acid test for multiple organisms A laboratory test that uses amplified probe techniques to detect the genetic material of multiple organisms in a sample. |
450 | $69 | $234 |
| Vaginal fluid RNA bacterial test A laboratory test that measures the RNA of bacteria found in a vaginal fluid specimen. |
413 | $139 | $428 |
| HPV high-risk type nucleic acid test A laboratory test that uses nucleic acid detection to identify high-risk types of human papillomavirus. |
282 | $34 | $117 |
| Mycoplasma genitalium DNA/RNA test A laboratory test that uses DNA or RNA probes to detect the presence of Mycoplasma genitalium bacteria in a sample. |
208 | $34 | $117 |
| Pap test A screening test to check for cervical cancer by collecting cells from the cervix. |
140 | $17 | $97 |
| Tissue staining for diagnosis, additional An extra laboratory procedure to apply special stains to tissue slides for detailed examination. |
131 | $64 | $277 |
| HPV high-risk type test for cervical cancer screening This test detects high-risk types of human papillomavirus (HPV) DNA or RNA. It is used for cervical cancer screening and must be performed in addition to a Pap test. |
113 | $34 | $117 |
| Yeast/candida DNA test A laboratory test that uses an amplified probe technique to detect the presence of Candida species, a type of yeast, in a patient sample. |
106 | $34 | $117 |
| Trichomonas vaginalis nucleic acid test A laboratory test that uses an amplified probe technique to detect the genetic material of the Trichomonas vaginalis parasite. This method identifies the presence of the organism responsible for trichomoniasis. |
82 | $33 | $117 |
| Herpes simplex virus nucleic acid test A laboratory test that uses an amplified probe technique to detect the genetic material of the herpes simplex virus. |
79 | $34 | $117 |
| Automated cervical/vaginal cancer screening with manual review An automated system screens cervical or vaginal cells for abnormalities, followed by a manual review and interpretation by a physician. |
77 | $22 | $66 |
| HPV DNA test for types 16 and 18 A laboratory test that uses nucleic acid detection to identify the presence of human papillomavirus types 16 and 18. |
70 | $40 | $122 |
| Chlamydia trachomatis nucleic acid amplification test A laboratory test that uses nucleic acid amplification to detect the presence of Chlamydia trachomatis bacteria in a sample. |
59 | $34 | $117 |
| Gonorrhea nucleic acid amplification test A laboratory test that uses amplified probe techniques to detect the genetic material of gonorrhea bacteria. This method identifies the presence of the infection by analyzing nucleic acids from the sample. |
59 | $34 | $117 |
| Tissue staining for diagnosis, initial A laboratory test where special stains are applied to tissue slides to help examine the cells and identify specific characteristics. |
57 | $74 | $325 |
| Manual microscopic genetic analysis of tumor A laboratory test that uses a microscope to manually examine tumor tissue for genetic changes. |
40 | $92 | $389 |
| Special stain test for organisms A laboratory test using special stains on tissue slides to identify microorganisms. The process includes the technical preparation of the slides and a professional interpretation of the results. |
26 | $84 | $306 |
| Pathology tissue examination, moderate complexity A laboratory test where a pathologist examines tissue samples under a microscope to identify abnormalities. This specific level indicates a moderate degree of complexity in the analysis. |
13 | $32 | $123 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
All-time payments by company (2018-2024) ›
Associated products mentioned in payments ›
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Galindo is a mixed practice specialist, with above-average Medicare volume (top 5% in PA), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Galindo experienced with automated cervical cancer screening with manual review?
Does Dr. Galindo receive payments from pharmaceutical companies?
How do Dr. Galindo's costs compare to other cytopathology physicians in Darby?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology